Galectin Therapeutics Inc.
$3.89
$0.18 (+4.85%)
$3.68Day Range$3.92
Key Statistics
Market Cap
$392.31M
Shares Outstanding
100.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 4, 2002
Round Lot
100
Locale
US
Trading Data
Day Open
$3.71
Day High
$3.92
Day Low
$3.68
Volume
1.07M
VWAP
$3.87
Prev Close
$3.71
Transactions
--
Acc. Volume
--
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
PHARMACEUTICAL PREPARATIONSSIC 28349 employees4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA, 30071678-620-3186IPO Sep 4, 2002US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001133416
- Composite FIGI
- BBG000BK6FP5
- Share Class FIGI
- BBG001S9NYW2
- Ticker Root
- GALT
- SIC Code
- 2834
About Galectin Therapeutics Inc. (GALT) Stock
Galectin Therapeutics Inc. (GALT) closed the 2026-09-18 session at $3.89, up 4.85% versus the previous close (+0.18). The stock opened at $3.71 and traded between $3.68 and $3.92 during that session. Session trading volume was 1.1M shares. The volume-weighted average price (VWAP) is $3.87.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Galectin Therapeutics Inc. has a market capitalization of $392.3 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. GALT is listed on the XNAS exchange. The company employs approximately 9 people. Galectin Therapeutics Inc. is headquartered in NORCROSS, GA. The recorded listing date is 2002-09-04.
On this page you can find market GALT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.